How Clinical Trial Teams Are Using AI Today to Work Smarter, Move Faster, and Stay Ahead
Join experts as they reveal how AI is being used today across feasibility, site selection, and trial strategy — and why success depends on pairing AI with high-quality, expert-backed data.
Richard Young
Chief Strategy Officer
View profile
Chief Strategy Officer
CluePoints
Richard holds a Biochemistry degree from Coventry University and brings thirty years of experience in clinical data management. His career started at Glaxo and he quickly went on to assume leadership roles at Parexel, Cmed, Medidata, and Veeva Systems. In October 2024, he joined CluePoints as Chief Strategy Officer, guiding their growth into a multi-product company.
Richard holds a Biochemistry degree from Coventry University and brings thirty years of experience in clinical data management. His career started at Glaxo and he quickly went on to assume leadership roles at Parexel, Cmed, Medidata, and Veeva Systems. In October 2024, he joined CluePoints as Chief Strategy Officer, guiding their growth into a multi-product company.
Kerri Cali
Executive Director/Head of Clinical Operations
View profile
Executive Director/Head of Clinical Operations
Recursion
With over 15 years of clinical development operations experience, Kerri Cali is a seasoned leader adept at navigating the complexities of drug development across therapeutic areas, from early- to late-phase studies. She brings a creative and strategic approach to problem-solving, collaborating with and leading cross-functional teams to drive innovation and leverage technology to transform challenges into opportunities. Her extensive journey has taken her through impactful roles at trial sites, Contract Research Organizations (CROs), and biotech companies, providing a truly holistic and comprehensive understanding of the clinical trial landscape.
With over 15 years of clinical development operations experience, Kerri Cali is a seasoned leader adept at navigating the complexities of drug development across therapeutic areas, from early- to late-phase studies. She brings a creative and strategic approach to problem-solving, collaborating with and leading cross-functional teams to drive innovation and leverage technology to transform challenges into opportunities. Her extensive journey has taken her through impactful roles at trial sites, Contract Research Organizations (CROs), and biotech companies, providing a truly holistic and comprehensive understanding of the clinical trial landscape.
Kerri's dedication to this field isn't merely professional; it's deeply personal. Having witnessed firsthand the profound impact diseases like cancer have had on family and friends, she is committed to the mission: to accelerate medical advancements and ensure clinical trials fulfill their incredible potential to genuinely improve and transform patients' lives.
